Skip to main content

Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · IEX Real-Time Price · USD
127.30
+0.12 (0.09%)
After-hours:Oct 22, 2021 6:28 PM EDT
127.18
-0.22 (-0.17%)
At close: Oct 22, 4:00 PM
Market Cap8.03B
Revenue (ttm)604.84M
Net Income (ttm)6.56M
Shares Out62.72M
EPS (ttm)0.10
PE Ratio1,234.76
Forward PE178.57
Dividendn/a
Ex-Dividend Daten/a
Volume358,044
Open127.58
Previous Close127.40
Day's Range125.79 - 128.50
52-Week Range76.19 - 136.10
Beta0.25
AnalystsBuy
Price Target134.40 (+5.7%)
Est. Earnings DateNov 3, 2021

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. ...

IndustryHealth Care Equipment & Supplies
IPO DateNov 14, 2013
CEOJohn Sheridan
Employees1,500
Stock ExchangeNASDAQ
Ticker SymbolTNDM
Full Company Profile

Financial Performance

In 2020, TNDM's revenue was $498.83 million, an increase of 37.68% compared to the previous year's $362.31 million. Losses were -$34.38 million, 38.9% more than in 2019.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is 134.40, which is an increase of 5.68% from the latest price.

Price Target
$134.40
(5.68% upside)
Analyst Consensus: Buy

News

Here's Why You Should Retain Tandem Diabetes (TNDM) for Now

Investors are optimistic about Tandem Diabetes (TNDM) owing to robust international pump shipments and product launches.

2 weeks ago - Zacks Investment Research

Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the fin...

2 weeks ago - Business Wire

Here's Why Tandem Diabetes Care, Inc. (TNDM) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago - Zacks Investment Research

Tandem Diabetes (TNDM) Rides on Innovation Despite Cost Woes

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 insulin pumps by both new and existing users is encouraging.

1 month ago - Zacks Investment Research

Why Tandem Diabetes Care Stock Jumped Today

The stock is being added to the S&P MidCap 400 Index.

1 month ago - The Motley Fool

This Simple Thing Sent These 3 Nasdaq Stocks Soaring Tuesday

All it takes is money -- big money.

Other symbols:MTCHQURE
1 month ago - The Motley Fool

Tandem Diabetes Care, Inc. (TNDM) Up 3.2% Since Last Earnings Report: Can It Continue?

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company ...

1 month ago - Business Wire

Here's Why You Should Invest In Tandem Diabetes (TNDM) Now

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 technology and international expansion of the Control-IQ technology add to the company's solid second-quarter performance.

1 month ago - Zacks Investment Research

5 Stocks Insiders Are Selling

When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock.

Other symbols:LEVIPTONSBACTWTR
2 months ago - Benzinga

Tandem Diabetes (TNDM) Q2 Earnings Rise Y/Y, Sales View Up

Tandem Diabetes (TNDM) reports better-than-expected revenues for second quarter 2021 on strong domestic and international pump shipments driving the top line.

2 months ago - Zacks Investment Research

Tandem Diabetes Care, Inc. (TNDM) Surpasses Q2 Earnings and Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of 175.00% and 19.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quart...

2 months ago - Business Wire

Tandem Diabetes Care Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company ...

2 months ago - Business Wire

Will Tandem Diabetes Care, Inc. (TNDM) Report Negative Earnings Next Week? What You Should Know

Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2021 results after the fi...

3 months ago - Business Wire

Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technolog...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Tandem Diabetes Care today presented positive real-world data from ongoing use of Control-IQ advanced hybrid closed-loop technology.

3 months ago - Business Wire

Diabetes Space Thrives on CGM Devices in 2021: 3 Stocks in Focus

CGM device stocks Medtronic (MDT), Dexcom (DXCM) and Tandem Diabetes (TNDM) are expected to continue their run over the next few months.

Other symbols:ABTDXCMMDT
3 months ago - Zacks Investment Research

2 Unstoppable Growth Stocks That Can Make You Richer Than Dogecoin

These two companies are less volatile than the cryptocurrency, and they offer better long-term prospects, too.

Other symbols:VEEV
4 months ago - The Motley Fool

Tandem (TNDM) Presents Data Backing Control-IQ Technology

Data presented at the ATTD conference demonstrates Tandem Diabetes Care's (TNDM) Control-IQ technology's ability to make a positive and sustained impact on diabetes care.

4 months ago - Zacks Investment Research

Tandem Diabetes Care Announces Presentations Demonstrating Immediate and Sustained Real-World Improvements with Contr...

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care announced positive real-world data from Control-IQ advanced hybrid closed-loop technology at international diabetes conference.

4 months ago - Business Wire

Why Is Tandem Diabetes Care, Inc. (TNDM) Up 0.2% Since Last Earnings Report?

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now

Investors continue to be optimistic about Tandem Diabetes (TNDM) on strong quarterly results and robust pump sales.

5 months ago - Zacks Investment Research

Tandem (TNDM) Global Growth Strong, Costs Continue to Rise

Tandem Diabetes (TNDM) is witnessing high international demand for the t:slim X2 pump.

5 months ago - Zacks Investment Research